GENEVA, June 24 -- GENEXINE, INC. filed a patent application (KR2025/016027) for “SINGLE DOMAIN ANTIBODY SPECIFICALLY BINDING TO SOX2, FUSION PROTEIN INCLUDING SAME, AND USE THEREOF”. With publication no. WO/2026/079930, here are the other details related to the patent application:
Kind: Later publication of international search report [A3]
IPC: C07K 16/18
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....